| Trial ID: | L6665 |
| Source ID: | NCT00543361
|
| Associated Drug: |
Mk0767
|
| Title: |
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MK0767|DRUG: Comparator: placebo (unspecified)|DRUG: Comparator: metformin
|
| Outcome Measures: |
Primary: This study will assess the lipid lowering effectiveness of MK0767 compared to metformin over the course of 52 weeks., over the course of 52 weeks | Secondary: MK0767 will be safe and well tolerated., over the course of 52 weeks
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
382
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-05
|
| Completion Date: |
2003-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-06-12
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00543361
|
